June 4, 2025
Attogene Corp. presented its groundbreaking RNaseAlarm Lateral Flow Assay at the RNA Society Annual Conference 2025 held in San Diego. This premier global event brings together leading academic and industrial scientists to present the latest advancements in RNA research.
Attogene was honored with an invitation to deliver an oral presentation in the New Technologies session of the conference, highlighting the company’s commitment to advancing RNA science. The presentation, delivered by Dr. Joe Krebs, Chief Technology Officer at Attogene, introduced the RNaseAlarm rapid test, a novel tool designed to detect ribonuclease (RNase) contamination in both liquid samples and on hard surfaces.
Dr. Krebs emphasized the critical importance of RNase detection in maintaining the integrity of RNA-based workflows, particularly in research, diagnostics, and biomanufacturing. The RNaseAlarm™ test offers a highly sensitive, fast, reliable, and user-friendly solution for identifying RNase contamination throughout the supply chain, as well as in laboratory and manufacturing environments.
“Our mission at Attogene is to empower scientists and quality control professionals with effective tools that ensure the highest standards of RNA integrity,” said Dr. Krebs. “RNaseAlarm represents a significant step forward in contamination detection, providing rapid results that help safeguard critical RNA processes.” The RNA Society Annual Meeting continues to serve as a vital platform for unveiling transformative technologies, and Attogene’s participation underscores its role as a key innovator in the RNA research community.
Oral presentation of the RNaseAlarm test at the 2025 RNA Society meeting in San Diego by Dr. Joe Krebs.